home / stock / sndx / sndx short
Short Information | Syndax Pharmaceuticals Inc. (NASDAQ:SNDX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,965,151 |
Total Actual Volume | 24,688,822 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 98,258 |
Average Short Percentage | 8.64% |
Is there a SNDX Short Squeeze or Breakout about to happen?
See the SNDX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $21.52 | $20.66 | $21.57 | $20.605 | 881,226 | 58,022 | 6.58% |
07-01-2024 | $20.39 | $21.53 | $21.7 | $20.28 | 1,037,219 | 68,049 | 6.56% |
06-28-2024 | $20.73 | $20.53 | $20.85 | $20.03 | 3,362,978 | 145,544 | 4.33% |
06-27-2024 | $19.94 | $20.32 | $20.37 | $19.58 | 1,138,815 | 125,990 | 11.06% |
06-26-2024 | $19.71 | $19.88 | $20.2099 | $19.12 | 1,114,369 | 97,627 | 8.76% |
06-25-2024 | $19.75 | $19.54 | $19.83 | $19.36 | 516,915 | 39,011 | 7.55% |
06-24-2024 | $20.12 | $19.8 | $20.67 | $19.77 | 1,045,769 | 45,305 | 4.33% |
06-21-2024 | $19.4 | $20.05 | $20.32 | $19.4 | 2,837,122 | 97,293 | 3.43% |
06-20-2024 | $18.97 | $19.27 | $19.39 | $18.6875 | 1,035,465 | 144,337 | 13.94% |
06-18-2024 | $19.92 | $19.06 | $19.93 | $18.92 | 993,936 | 139,442 | 14.03% |
06-17-2024 | $20 | $19.88 | $20.11 | $19.64 | 936,804 | 87,301 | 9.32% |
06-14-2024 | $20.52 | $20.11 | $20.55 | $19.98 | 783,089 | 79,704 | 10.18% |
06-13-2024 | $20.4 | $20.7 | $20.79 | $19.97 | 879,093 | 62,196 | 7.08% |
06-12-2024 | $19.97 | $20.27 | $20.79 | $19.6 | 1,648,178 | 193,183 | 11.72% |
06-11-2024 | $19.46 | $19.32 | $19.65 | $19.165 | 964,685 | 151,730 | 15.73% |
06-10-2024 | $19.74 | $19.72 | $19.92 | $19.03 | 1,239,024 | 158,452 | 12.79% |
06-07-2024 | $19.15 | $19.5 | $19.67 | $18.82 | 979,835 | 60,505 | 6.18% |
06-06-2024 | $19.1 | $19.4 | $19.62 | $18.65 | 1,169,591 | 72,659 | 6.21% |
06-05-2024 | $18.93 | $19.21 | $19.3925 | $18.72 | 1,241,560 | 79,499 | 6.4% |
06-04-2024 | $19.18 | $18.82 | $19.33 | $18.69 | 883,149 | 59,302 | 6.71% |
News, Short Squeeze, Breakout and More Instantly...
Syndax Pharmaceuticals Inc. Company Name:
SNDX Stock Symbol:
NASDAQ Market:
Syndax Pharmaceuticals Inc. Website:
PALM BEACH, Fla., June 17, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow. It is characterized by the rapid growth of abnormal myeloid cells, which are immature blood cells that normally...
Syndax Presents Updated Positive Data from BEAT AML and AUGMENT-102 Phase 1/2 Combination Trials of Revumenib in Patients with Acute Leukemias at EHA 2024 Congress PR Newswire - Data continue to support revumenib's potential to enhance current standard of care agents - ...
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Michael A. Metzger to its Board of Directors, effecti...